NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/19/2026
Back to search
Official data from USPTO
NEXTKIDNEY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEXTKIDNEY
ST13
US500000079292148Class
5, 10, 42
Filing
79292148
Registration
6504496
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
02/20/2026
Trademark type
Word
Nice classes
5, 10, 42
Filing date
05/15/2020
Registration date
10/05/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/05/2021
Last transaction
02/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
STADELI, MARTA ANN
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Nextkidney SA
Debiotech SA
Representatives
Duane M. Byers Nixon & Vanderhye PC
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for therapy related to dialysispharmaceutical solutions and concentrates used in dialysis therapy; pharmaceutical preparations used in dialysis treatment
Class 10
Medical instrumentsinjection devices for pharmaceutical products; medical instruments and apparatus and medical devices all used in dialysis treatmentdialysis machinesdialyzersfilters for dialysis fluidsmonitors for dialysis machinescontinuous renal treatment machineshemofiltration and hemodialysis machinesall for dialysis treatment and parts thereof; medical bags for medical fluids used in dialysis; dialysis pumps; medical syringes; needles for medical use; dialysis catheters; cannulae; closure caps for catheters; tubes for use in dialysis; locks for catheters; medical apparatus for dialysis treatment also equipped with adapters and connectors
Class 42
Research and development of medical devices in the field of dialysisrenal replacement therapy and medical laboratory services
Publications
History of USPTO decisions and trademark events.
32 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/01/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/05/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/10/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/22/2022
FIMP
FINAL DISPOSITION PROCESSED
03/22/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/20/2021
PUBO
PUBLISHED FOR OPPOSITION
07/20/2021
GPNX
NOTIFICATION PROCESSED BY IB
07/18/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/30/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/30/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/30/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/16/2021
DMCC
DATA MODIFICATION COMPLETED
06/16/2021
ALIE
ASSIGNED TO LIE
06/16/2021
NREV
NOTICE OF REVIVAL - E-MAILED
06/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/06/2021
PETG
PETITION TO REVIVE-GRANTED
06/06/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
06/06/2021
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
04/12/2021
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
04/10/2021
RFNT
REFUSAL PROCESSED BY IB
10/19/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/27/2020
RFRR
REFUSAL PROCESSED BY MPU
09/27/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/28/2020
CNRT
NON-FINAL ACTION WRITTEN
08/27/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/25/2020
DOCK
ASSIGNED TO EXAMINER
08/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/20/2020
Continuous trademark protection
Get notified about every new filing that threatens NEXTKIDNEY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.